Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1

被引：0
|
作者：
不详
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 2014年 / 161卷 / 07期
关键词：
D O I：
10.7326/P14-9035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：I / 22
页数：1
相关论文
共 50 条
  • [31] Antiretroviral therapy options for treatment-naive patients with HIV-1
    Hedley, Lucy
    Minton, June
    Wallis, Gabriel
    Waters, Laura
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2015, 76 (08) : C122 - C125
  • [32] Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase
    Peter M. Grob
    Yunzhen Cao
    Elizabeth Muchmore
    David D. Ho
    Steve Norris
    Joseph W. Pav
    Cheng-Kon Shih
    Julian Adams
    Nature Medicine, 1997, 3 : 665 - 670
  • [33] The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults
    Mackie, Nicola E.
    Dunn, David T.
    Dolling, David
    Garvey, Lucy
    Harrison, Linda
    Fearnhill, Esther
    Tilston, Peter
    Sabin, Caroline
    Geretti, Anna M.
    AIDS, 2013, 27 (14) : 2245 - 2253
  • [34] Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase
    Grob, PM
    Cao, YZ
    Munchmore, E
    Ho, DD
    Norris, S
    Pav, JW
    Shih, CK
    Adams, J
    NATURE MEDICINE, 1997, 3 (06) : 665 - 670
  • [35] HBY 097 - a second-generation nonnucleoside inhibitor of the HIV-1 reverse transcriptase
    Kleim, JP
    TRENDS IN DRUG RESEARCH II, 1998, 29 : 117 - 119
  • [36] Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy
    Hare, C. Bradley
    Mellors, John
    Krambrink, Amy
    Su, Zhaohui
    Skiest, Daniel
    Margolis, David M.
    Patel, Sheran S.
    Barnas, Douglas
    Frenkel, Lisa
    Coombs, Robert W.
    Aweeka, Francesca
    Morse, Gene D.
    Haas, David W.
    Boltz, Valerie
    Palmer, Sarah
    Coffin, John
    Havlir, Diane V.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (03) : 421 - 424
  • [37] Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women
    Min, SS
    Corbett, AH
    Rezk, N
    Cu-Uvin, S
    Fiscus, SA
    Petch, L
    Cohen, MS
    Kashuba, ADM
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (05) : 1577 - 1580
  • [38] Validation of a model for the complex of HIV-1 reverse transcriptase with nonnucleoside inhibitor TMC125
    Udier-Blagovic, M
    Tirado-Rives, J
    Jorgensen, WL
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (20) : 6016 - 6017
  • [39] Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjects
    Blanckenberg, DH
    Wood, R
    Horban, A
    Beniowski, M
    Boron-Kaczmarska, A
    Trocha, H
    Halota, W
    Schmidt, RE
    Fatkenheuer, G
    Jessen, H
    Lange, JMA
    AIDS, 2004, 18 (04) : 631 - 640
  • [40] In Vitro Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor
    Lai, Ming-Tain
    Feng, Meizhen
    Falgueyret, Jean-Pierre
    Tawa, Paul
    Witmer, Marc
    DiStefano, Daniel
    Li, Yuan
    Burch, Jason
    Sachs, Nancy
    Lu, Meiqing
    Cauchon, Elizabeth
    Campeau, Louis-Charles
    Grobler, Jay
    Yan, Youwei
    Ducharme, Yves
    Cote, Bernard
    Asante-Appiah, Ernest
    Hazuda, Daria J.
    Miller, Michael D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (03) : 1652 - 1663
12345